Short- and long-term effects of erythropoietin treatment on endothelial progenitor cell levels in patients with cardiorenal syndrome

OBJECTIVE: Patients with cardiorenal syndrome (CRS) have high cardiovascular morbidity. Endothelial progenitor cells (EPC) constitute an endogenous vascular repairsystem, protecting against atherosclerosis development. Erythropoietin (EPO) treatment may have beneficial effects by mobilizing EPC from...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Jie, Kim E, van der Putten, Karien, Bergevoet, Marloes W T, Doevendans, Pieter A, Gaillard, Carlo A J M, Braam, Branko, Verhaar, Marianne C
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Group 2010
Témata:
Cardiorenal Syndrome
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3002834/
https://ncbi.nlm.nih.gov/pubmed/21071558
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/hrt.2010.194654
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky